FRED BAYON: Open Payments
NPI 1225031362 · VALLEJO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,084 in 82 payments from 20 companies in 2025. Trend: 2023 $2,411 · 2024 $2,297 · 2025 $2,084
Food & beverage: $2,084
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 11 | $331 |
| PFIZER INC. | 10 | $275 |
| GlaxoSmithKline, LLC. | 10 | $270 |
| Novo Nordisk Inc | 15 | $265 |
| ABBVIE INC. | 9 | $222 |
| Lilly USA, LLC | 4 | $101 |
| Merck Sharp & Dohme LLC | 3 | $88 |
| AstraZeneca Pharmaceuticals LP | 3 | $81 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $79 |
| Intra-Sana Laboratories | 2 | $60 |
Products named: JARDIANCE, NURTEC ODT, TRELEGY ELLIPTA, Ozempic, MOUNJARO, QULIPTA, Kerendia, VRAYLAR.
Industry payments across CA — which companies pay providers there.
